ICAI issue Technical Guide on Internal Audit of Pharmaceutical Industry
the Indian pharmaceutical industry is the world’s 13th largest by value and third largest in the world by volume. The pharmaceutical industry in India was valued at an estimated US $42 billion in 2021 and is estimated to reach $.130 billion by 2030. India is the world’s largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.
In view of the role and importance of the pharmaceutical industry, the ICAI has issued a Technical Guide on Internal Audit of Pharmaceutical Industry to provide guidance to internal auditors in carrying out internal audit of companies operating in pharmaceutical industry.
This Guide has been divided into ten chapters i.e. regulatory framework, key drivers of this industry, technical aspects, R&D, Risk Assessment, internal audit etc.
This technical guide aims to provide comprehensive information and guidance to internal auditors working in the domestic pharmaceutical industry. It aims to equip internal auditors with the knowledge necessary to effectively assess and evaluate the risk management and internal control systems, management processes and compliance frameworks specific to the pharmaceutical sector.
AO is under an obligation to duly consider the explanation furnished by the assessee and assign reasons for rejecting the…
CBIC issues SoP for clearance of imported goods through Foreign Post Offices under Postal Import Regulations, 2025. Standard Operating Procedure…
Sale deed executed with full knowledge of only part consideration paid, cannot be rendered void or inoperative merely for non…
No fault in serving notice u/s 148 to last known address when assessee had not updated change of address in…
Investment made by firm through capital introduced by partners cannot be treated as unexplained investment in the hands of the…
Multipurpose Empanelment Form (MEF)- 2026-27 is hosted - Last date for submission is 29.08.2026 ICAI has hosted the Multipurpose Empanelment…